P2Y12 inhibitor versus aspirin monotherapy for secondary prevention of cardiovascular events: meta-analysis of randomized trials
Document Type
Article
Publication Date
3-21-2022
Publication Title
European heart journal open
Abstract
AIM: To compare the efficacy and safety of P2Y
METHODS AND RESULTS: Medline, Embase, and Cochrane Central databases were searched to identify randomized trials comparing monotherapy with a P2Y
CONCLUSION: P2Y
Volume
2
Issue
2
First Page
oeac019
Recommended Citation
Aggarwal D, Bhatia K, Chunawala ZS, Furtado RHM, Mukherjee D, Dixon SR, et al P2Y12 inhibitor versus aspirin monotherapy for secondary prevention of cardiovascular events: meta-analysis of randomized trials. Eur Heart J Open. 2022 Mar 21;2(2):oeac019. doi: 10.1093/ehjopen/oeac019. PMID: 35919116.
DOI
10.1093/ehjopen/oeac019
ISSN
2752-4191
PubMed ID
35919116
COinS